MedPath

Effect of Smart Phone Health Education on Overweight and Obese Schoolchildren's Dietary Habits and Body Composition

Not Applicable
Completed
Conditions
Childhood Obesity
Interventions
Other: Smart Phone Education (mhealth)
Other: Paper Education (conventional)
Registration Number
NCT06247202
Lead Sponsor
Universiti Sains Malaysia
Brief Summary

The aim of this study is to investigate the effect of mobile health nutrition education intervention in the changing of dietary habits and body composition of overweight and obese 8-12 years old children in Sharjah, United Arab Emirates and to compare its effectiveness to paper educational intervention among the same age group.

The main questions it aims to answer are:

1. Are there any significant changes in dietary habits, physical activity and body composition among overweight and obese school-age children after three months of mobile health intervention?

2. Is there any significant difference between the effect of smart phone delivered and paper delivered interventions (changes in dietary habits, physical activity and body composition) among overweight and obese school-age children after three months of interventions?

3. Are there any significant changes in the obesity inflammatory panel among overweight and obese school-age children after three months of mobile health intervention?

4. Is there any significant difference in the sustainability of the outcomes between mobile health and paper delivered interventions among overweight and obese school-age children two months after the end of the intervention?

5. Are there any significant changes in nutrition related knowledge among parents of overweight and obese school-age children after three months of intervention?

Participants (children with their parents) will be randomly divided into intervention group and control group. Parents of children from the intervention group will receive two text messages/graphics per week about healthy eating and physical activity (PA) on their mobile phones during the intervention period (3 months). While parents in the control group will receive a one-time printed handout containing the same messages at the beginning of the intervention period.

Assessment of children's anthropometry, dietary intake and physical activity will be evaluated pre and post intervention and one more time after a two months period of maintenance after the end of the intervention. Parents' nutrition knowledge will be evaluated pre and post intervention only. Also, children salivary obesity markers will be measured at baseline and at the end of the intervention period to explore the effects of the intervention on inflammatory markers associated with obesity.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
146
Inclusion Criteria
  • Overweight/obese children (over 2 SD based on the WHO Growth Reference (2007)).
  • Between 8 - 12 years old.
  • Attending school in Sharjah, UAE.
Exclusion Criteria
  • Children on a specific diet.
  • Children who have any chronic diseases.

Parents qualify if their children meet the inclusion criteria, they can read and speak in Arabic, they plan to stay in Sharjah for six months from the beginning of the intervention, and they own and use a smart phone.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupSmart Phone Education (mhealth)Participants in the intervention group will receive smart phone delivered health education in the form of text messages through WhatsApp.
Control groupPaper Education (conventional)Participants in the control group will receive paper delivered health education in the form of a one time handout.
Primary Outcome Measures
NameTimeMethod
Weight3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

Body Mass Index3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

Will be calculated using the weight and height, and will be measured in kg/m\^2

Children's Physical Activity3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

Using a valid Physical Activity Questionnaire - no scale

Salivary C-Reactive Protein Concentrationtwice: before intervention (at 0 months) and after intervention (at 3 months).

Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

Salivary Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Concentrationtwice: before intervention (at 0 months) and after intervention (at 3 months).

Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

Salivary Complement Factor D (Adipsin) Concentrationtwice: before intervention (at 0 months) and after intervention (at 3 months).

Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

Salivary Leptin (OB) Concentrationtwice: before intervention (at 0 months) and after intervention (at 3 months).

Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

Body Fat Mass3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

Fat Free Mass3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

Parents' Knowledgetwice: before intervention (at 0 months) and after intervention (at 3 months).

Using a valid Nutrition Knowledge Attitude Practice Questionnaire - no scale

Salivary Tumour Necrosis Factor alpha (TNF alpha) Concentrationtwice: before intervention (at 0 months) and after intervention (at 3 months).

Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

Height3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

Will be measured using a standing Stadiometer, and will be measured in Centimetres

Total Body Water3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

Salivary Adiponectin (Acrp30) Concentrationtwice: before intervention (at 0 months) and after intervention (at 3 months).

Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

Salivary Interleukin 6 (IL-6) Concentrationtwice: before intervention (at 0 months) and after intervention (at 3 months).

Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

Children's Dietary Intake3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

Using 24 Hours' Diet recall (3 days).

Salivary Resistin Concentrationtwice: before intervention (at 0 months) and after intervention (at 3 months).

Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

Salivary Interleukin 10 (IL-10) Concentrationtwice: before intervention (at 0 months) and after intervention (at 3 months).

Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

Salivary Plasminogen Activator Inhibitor-1 (Serpin E1 / PAI-1) Concentrationtwice: before intervention (at 0 months) and after intervention (at 3 months).

Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Sharjah

🇦🇪

Sharjah, United Arab Emirates

© Copyright 2025. All Rights Reserved by MedPath